Leonard A Oppenheim
CIK 1307647 · last filed 2022-01-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$38.0K
Companies
4
Total Filings
42
Lifetime Open-Market Net
-$101.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XTI Aerospace, Inc. (INPX) Delisted | Director | 0 | $5.27 | $0 | $0 | 7 | 2022-01-10 |
| XTI Aerospace, Inc. (SYRX) Delisted | Director | 6,812 | — | — | $0 | 10 | 2017-02-07 |
| SEELOS THERAPEUTICS, INC. (APRI) Delisted | Director | 682 | — | — | -$37.9K | 9 | 2014-02-10 |
| NEXM | Director | 16,104 | $2.36 | $38.0K | -$63.4K | 15 | 2010-04-01 |
Recent Filings · Page 3 of 5
42 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-01-04 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +2,784 | $14.3K | EDGAR |
| 2011-10-04 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +2,784 | $10.0K | EDGAR |
| 2011-07-05 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +2,784 | $9.9K | EDGAR |
| 2011-05-18 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +2,784 | $9.9K | EDGAR |
| 2011-01-07 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +2,179 | $10.0K | EDGAR |
| 2010-10-04 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +2,179 | $10.0K | EDGAR |
| 2010-07-02 | — | Grant (A) | +2,179 | $10.0K | |
| 2010-04-01 | NEXM | Grant (A) | +32,680 | $10.0K | EDGAR |
| 2009-12-18 | NEXM | Sell (S) | −150,707 | -$63.4K | EDGAR |
| 2009-10-19 | NEXM | Grant (A) | +10,708 | $15.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.